Leheny A. Rachel 4
4 · CalciMedica, Inc. · Filed Nov 6, 2023
Insider Transaction Report
Form 4
Leheny A. Rachel
DirectorCHIEF EXECUTIVE OFFICER10% Owner
Transactions
- Purchase
Common Stock
2023-11-03$2.85/sh+5,000$14,250→ 14,400 total
Holdings
- 1,000(indirect: By Spouse)
Common Stock
- 316,109(indirect: By LLC)
Common Stock
- 356,989(indirect: By LLC)
Common Stock
- 66,228(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein.